Stryker invests $400M in CMR Surgical with option to acquire

Stryker is investing approximately US$400 million in UK surgical robotics developer CMR Surgical, securing an exclusive option to acquire the remaining equity. The agreement also gives Stryker exclusive US commercial agency rights for CMR's Versius surgical robotics portfolio.

“Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, described soft-tissue robotics as a high-growth opportunity and said the company had selected CMR after evaluating the sector over several years.”pharmafile.com

• 1 source
• pharmafile.comStryker invests US$400m in CMR Surgical and secures option to acquire business - PharmafileNov 3, 2026

Summarized from public sources; check the original articles before acting on it.